This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University System of Maryland. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: Mark D Kvarta: Innovator in Antidepressant Research
Introduction
Mark D Kvarta is a notable inventor based in Ellicott City, MD (US). He has made significant contributions to the field of medical research, particularly in the development of fast-acting antidepressants. His work focuses on the use of negative modulators of GABA receptors, which are crucial in treating depression and related conditions.
Latest Patents
Mark D Kvarta holds a patent for the "Use of negative modulators of GABA receptors containing alpha5 subunits as fast acting antidepressants." This patent outlines methods and compositions related to the treatment of various medical conditions using negative modulators of GABA receptors. Specifically, it addresses the treatment, amelioration, or prevention of depression and suicidability through the use of partial inverse agonists of GABA receptors that include an alpha5 subunit. He has 1 patent to his name.
Career Highlights
Mark is affiliated with the University System of Maryland, where he conducts his research and development work. His innovative approach to antidepressant therapies has positioned him as a key figure in the field of mental health treatment.
Collaborations
Throughout his career, Mark has collaborated with notable colleagues, including Scott Thompson and Adam Van Dyke. These partnerships have enhanced his research efforts and contributed to the advancement of his projects.
Conclusion
Mark D Kvarta's work in the realm of antidepressant research exemplifies the impact of innovative thinking in medicine. His contributions are paving the way for new treatment options for individuals suffering from depression.